Point: PROTECTED TAVR – The Case for CEPD
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - Novartis; Edwards Lifesciences
- Consultant Fee/Honoraria/Speaker's Bureau - Medtronic; Abiomed; Edwards Lifesciences; Boston Scientific Corporation; AstraZenca; Novartis; Pfizer; Bayer AG; Boehringer
- Equity/Stock(s)/Options - Claret Medical Inc; Picardia; Transverse Medical